Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment

Tundra lists 1 Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT05520892

Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children

To compare the efficacy of two different dosage regimens of intravenous immune globulin (IVIG) in the treatment of children with newly diagnosed immune thrombocytopenia, and to reduce related adverse reactions and economic burdens on the premise of ensuring the remission rate

Gender: All

Ages: 29 Days - 14 Years

Updated: 2024-05-16

1 state

Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment